Brought to you by Adobe
- Adobe® Acrobat® 9 Pro Extended - a complete PDF solution
- Create interactive presentations
- Bring people & ideas together
- Communicate with impact
Featured White Papers
- Aug. 28th: Delivering Online Presentations That Result in Higher Sales (Citrix Online)
- 9 critical reasons to automate performance management (SuccessFactors, Inc.)
- The missing link: Driving business results through pay-for-performance (SuccessFactors, Inc.)
Content provided in partnership with
Technology Industry
Industry: Email Alert RSS FeedAaiPharma Inc
BT Catalyst, Sept, 2001
AaiPharma Inc. (Nasdaq: AAII) of Wilmington has received two U.S. patents for omeprazole. Patent No. 6,262,085, "Alkoxy Substituted Benzimidazole Compounds, Pharmaceutical Preparations Containing the Same, and Methods of Using the Same;" and Patent No. 6,262,086, "Pharmaceutical Unit Dosage Form," were issued in July.
Omeprazole is marketed under the brand names Prilosec [R] and Losec [R] by AstraZeneca PLC (NYSE: AZN) of London. It is a proton-pump inhibitor used for the treatment of active duodenal ulcers, benign gastric ulcers, erosive esophogitis and gastroesophageal reflux disease and related heartburn.
COPYRIGHT 2001 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »